A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia

Previous studies suggest that sepsis remains a common critical illness with a global incidence of 31.5 million. The aim of this study was to evaluate the comparative therapeutic value of recombinant human thrombopoietin (rhTPO) in treating sepsis patients with thrombocytopenia. We conducted a compre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dandan, Hou, Yu, Wei, Chaochao, Cai, Xingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822753/
https://www.ncbi.nlm.nih.gov/pubmed/36683598
http://dx.doi.org/10.1155/2022/2124019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822753/
https://www.ncbi.nlm.nih.gov/pubmed/36683598
http://dx.doi.org/10.1155/2022/2124019

Ejemplares similares